跳至主要内容
临床试验/NL-OMON49009
NL-OMON49009招募中不适用

A two part bioavailability study on synthetic THC containing chewing gum formulations in healthy male and female volunteers. - CS0325 Axim THC

Axim Biotechnologies B.V. .0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • •- Subject is willing to give written informed consent.
  • •- Subject is a healthy male or female between 18 and 55 years of age,
  • •inclusive, at Screening.
  • •- A body mass index (BMI) in the range of >=18.0 kg/m2 and <=30.0 kg/m2 at
  • •- Subject is in good health as judged by the Investigator and based on medical
  • •history, physical examination, vital sign measurements, ECG, and laboratory
  • •safety tests performed at Screening.
  • •Please refer to the protocol for more inclusion criteria.

排除标准

  • •- Women who are pregnant or nursing, or planning to do so soon.
  • •- Subject is mentally or legally incapacitated, has significant emotional
  • •problems at the time of Screening or is expected to get significant emotional
  • •problems during the conduct of the study or has a history of clinically
  • •significant psychiatric disorder within the last 5 years.
  • •- Subject has a history of clinically significant endocrine, gastrointestinal,
  • •cardiovascular, hematological, hepatic, immunological, renal, respiratory,
  • •genitourinary or major neurological (including stroke and chronic seizures)
  • •abnormalities or diseases. Subjects with a history of cholecystectomy,
  • •uncomplicated kidney stones, as defined as spontaneous passage and no
  • •recurrence in the last 5 years, or childhood asthma may be enrolled in the
  • •study at the discretion of the investigator.
  • •Please refer to the protocol for more exclusion criteria.

研究者

发起方
Axim Biotechnologies B.V. .

相似试验